Upcoming FDA-AACR-ASA Workshop to Examine Overall Survival in Oncology Clinical Trials
When faced with a cancer diagnosis, patients often find themselves asking, “How long will I live? Which treatments will...
Category: Policy
When faced with a cancer diagnosis, patients often find themselves asking, “How long will I live? Which treatments will...
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
A study that examined the catchment areas of 102 cancer centers in the U.S. found that while over a...
An individual with hypertension visits their primary care physician and learns that two new medications for their condition have...
Although not common, a cancer diagnosis during pregnancy or the onset of a pregnancy while a woman is receiving...
When Monica Bertagnolli, MD, was appointed director of the National Cancer Institute in 2022, she became the first woman...
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
Throughout his career as a cancer researcher, Robert A. Winn, MD, has seen a familiar pattern in progress. Each...
The end of the year presents a unique opportunity to look back on recent accomplishments, take inventory of successes...
By Kaleem Zaidi, PhDAACR Executive Office The year 2022 marked significant progress against cancer, thanks to advances in cancer...